MACM
March Altus Capital Management Portfolio holdings
AUM
$16M
This Quarter Return
+16.4%
1 Year Return
+18.92%
3 Year Return
+153.93%
5 Year Return
–
10 Year Return
–
AUM
$214M
AUM Growth
+$214M
(-13%)
Cap. Flow
-$54.1M
Cap. Flow
% of AUM
-25.25%
Top 10 Holdings %
Top 10 Hldgs %
60.25%
Holding
33
New
9
Increased
2
Reduced
10
Closed
11
Top Buys
| 1 |
Amgen
AMGN
|
$12.8M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$12.2M |
| 3 |
MDCO
Medicines Co
MDCO
|
$12.1M |
| 4 |
Align Technology
ALGN
|
$11M |
| 5 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$9.67M |
Top Sells
| 1 |
AEGR
Aegerion Pharmaceuticals, Inc.
AEGR
|
$13.5M |
| 2 |
Johnson & Johnson
JNJ
|
$13M |
| 3 |
ZLTQ
ZELTIQ Aesthetics, Inc.
ZLTQ
|
$12.2M |
| 4 |
Biogen
BIIB
|
$10.9M |
| 5 |
ACOR
Acorda Therapeutics, Inc.
ACOR
|
$10.3M |
Sector Composition
| 1 | Healthcare | 83.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
United Therapeutics
UTHR
$18.1B
| $14.9M | 6.81% |
115,077
-54,475
| -32% | -$7.05M |
|
2
DexCom
DXCM
$31B
| $14.7M | 6.72% |
267,076
-117,477
| -31% | -$6.47M |
|
|
MNK
3
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $14.4M | 6.56% |
145,071
-51,105
| -26% | -$5.06M |
|
4
Universal Health Services
UHS
$11.6B
| $13.7M | 6.25% |
122,904
+30,097
| +32% | +$3.35M |
|
|
5
Amgen
AMGN
$152B
| $12.8M | 5.86% |
+80,600
| New | +$12.8M |
|
|
ALXN
6
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $12.2M | 5.57% |
65,960
-1,120
| -2% | -$207K |
|
|
7
Regeneron Pharmaceuticals
REGN
$60.3B
| $12.2M | 5.55% |
+29,620
| New | +$12.2M |
|
|
MDCO
8
DELISTED
Medicines Co
MDCO
| $12.1M | 5.51% |
+435,986
| New | +$12.1M |
|
9
West Pharmaceutical
WST
$17.6B
| $11.2M | 5.13% |
210,910
+72,112
| +52% | +$3.84M |
|
|
10
Align Technology
ALGN
$9.61B
| $11M | 5.01% |
+196,368
| New | +$11M |
|
11
Eli Lilly
LLY
$658B
| $10.7M | 4.9% |
155,417
-46,031
| -23% | -$3.18M |
|
|
UAM
12
DELISTED
Universal American Corp
UAM
| $10.5M | 4.78% |
1,128,043
-985
| -0.1% | -$9.14K |
|
|
WCG
13
DELISTED
Wellcare Health Plans, Inc.
WCG
| $9.67M | 4.42% |
+117,823
| New | +$9.67M |
|
14
Humana
HUM
$37.6B
| $8.85M | 4.04% |
+61,581
| New | +$8.85M |
|
|
CYNO
15
DELISTED
Cynosure, Inc. Class A
CYNO
| $8.66M | 3.95% |
+315,717
| New | +$8.66M |
|
16
Select Medical
SEM
$1.59B
| $7.83M | 3.57% |
543,455
-154,701
| -22% | -$2.23M |
|
|
AVDL
17
Avadel Pharmaceuticals
AVDL
$1.4B
| $6.77M | 3.09% |
+394,897
| New | +$6.77M |
|
|
ENZY
18
DELISTED
Enzymotec Ltd
ENZY
| $5.13M | 2.34% |
681,778
| – | – |
|
|
AMAG
19
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $4.82M | 2.2% |
113,079
-225,644
| -67% | -$9.62M |
|
20
Zoetis
ZTS
$67.5B
| $4.55M | 2.08% |
105,822
-184,692
| -64% | -$7.95M |
|
21
Encompass Health
EHC
$12.4B
| $4.15M | 1.89% |
107,885
-244,759
| -69% | -$9.41M |
|
22
Incyte
INCY
$17B
| $3.6M | 1.64% |
+49,217
| New | +$3.6M |
|
|
23
Biogen
BIIB
$20.9B
| – | – |
-32,986
| Closed | -$10.9M |
|
24
Cencora
COR
$57.1B
| – | – |
-127,799
| Closed | -$9.88M |
|
25
HCA Healthcare
HCA
$95.1B
| – | – |
-144,586
| Closed | -$10.2M |
|